Alessandro Inno

3.0k total citations
80 papers, 1.2k citations indexed

About

Alessandro Inno is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Alessandro Inno has authored 80 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Oncology, 29 papers in Pulmonary and Respiratory Medicine and 16 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Alessandro Inno's work include Cancer Immunotherapy and Biomarkers (20 papers), Colorectal Cancer Treatments and Studies (15 papers) and Chemotherapy-induced cardiotoxicity and mitigation (14 papers). Alessandro Inno is often cited by papers focused on Cancer Immunotherapy and Biomarkers (20 papers), Colorectal Cancer Treatments and Studies (15 papers) and Chemotherapy-induced cardiotoxicity and mitigation (14 papers). Alessandro Inno collaborates with scholars based in Italy, United States and Japan. Alessandro Inno's co-authors include Stefania Gori, Antonio Russo, Fausto Petrelli, Antonio Ghidini, Lorenzo Belluomini, Simona Duranti, Zeno Bisoffi, Guido Arcaro, Paolo Bocus and Monica Turazza and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and International Journal of Molecular Sciences.

In The Last Decade

Alessandro Inno

76 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alessandro Inno Italy	20	695	329	258	184	154	80	1.2k
Mehmet Alı Nahıt Şendur Türkiye	18	825 1.2×	446 1.4×	292 1.1×	158 0.9×	98 0.6×	183	1.4k
Ηλίας Κοττέας Greece	18	570 0.8×	330 1.0×	319 1.2×	193 1.0×	126 0.8×	76	1.1k
Jérôme Alexandre France	20	823 1.2×	528 1.6×	360 1.4×	187 1.0×	181 1.2×	100	1.7k
Javier Gómez United States	18	361 0.5×	373 1.1×	270 1.0×	122 0.7×	86 0.6×	51	1.0k
Anne Dyhl-Polk Denmark	16	654 0.9×	200 0.6×	178 0.7×	125 0.7×	91 0.6×	20	1.1k
David Liska United States	19	712 1.0×	280 0.9×	257 1.0×	132 0.7×	194 1.3×	151	1.2k
Yuichiro Takeda Japan	20	780 1.1×	629 1.9×	387 1.5×	118 0.6×	117 0.8×	123	1.6k
Luigi Di Lauro Italy	25	886 1.3×	307 0.9×	398 1.5×	328 1.8×	213 1.4×	113	1.7k
Philipp K. Haber Germany	16	504 0.7×	409 1.2×	223 0.9×	239 1.3×	195 1.3×	33	1.6k
Νicolas Tsavaris Greece	22	999 1.4×	495 1.5×	259 1.0×	149 0.8×	161 1.0×	87	1.7k

Countries citing papers authored by Alessandro Inno

Since Specialization

Citations

This map shows the geographic impact of Alessandro Inno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alessandro Inno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alessandro Inno more than expected).

Fields of papers citing papers by Alessandro Inno

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alessandro Inno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alessandro Inno. The network helps show where Alessandro Inno may publish in the future.

Co-authorship network of co-authors of Alessandro Inno

This figure shows the co-authorship network connecting the top 25 collaborators of Alessandro Inno. A scholar is included among the top collaborators of Alessandro Inno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alessandro Inno. Alessandro Inno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gallucci, Giuseppina, Alessandro Navazio, Fabio Maria Turazza, et al.. (2025). Atherosclerosis and the Bidirectional Relationship Between Cancer and Cardiovascular Disease: From Bench to Bedside, Part 2 Management. International Journal of Molecular Sciences. 26(1). 334–334. 3 indexed citations

Tarantini, Luigi, Giuseppina Gallucci, Alessandro Inno, et al.. (2025). A New Era, New Risks: The Cardio-Oncology Perspective on Immunotherapy in Non-Small Cell Lung Cancer. Cancers. 17(21). 3443–3443.

Quagliariello, Vincenzo, Vincenzo Giordano, Michele Barbato, et al.. (2024). SOLUBLE GUANYLATE CYCLASE ACTIVATOR VERICIGUAT PREVENTS ANTHRACYCLINE–MEDIATED CARDIOTOXICITY AND SARCOPENIA THROUGH NO–SGC–CGMP–NLRP3 PATHWAY: POTENTIAL APPLICATION IN CANCER PATIENTS. European Heart Journal Supplements. 26(Supplement_2). ii31–ii31. 1 indexed citations

Quagliariello, Vincenzo, Massimiliano Berretta, Maria Laura Canale, et al.. (2024). The sGCa Vericiguat Exhibit Cardioprotective and Anti-Sarcopenic Effects through NLRP-3 Pathways: Potential Benefits for Anthracycline-Treated Cancer Patients. Cancers. 16(8). 1487–1487. 10 indexed citations

Foti, Giovanni, Giorgio Ascenti, Andrea Agostini, et al.. (2024). Dual-Energy CT in Oncologic Imaging. Tomography. 10(3). 299–319. 9 indexed citations

Gallucci, Giuseppina, Fabio Maria Turazza, Alessandro Inno, et al.. (2024). Atherosclerosis and the Bidirectional Relationship between Cancer and Cardiovascular Disease: From Bench to Bedside—Part 1. International Journal of Molecular Sciences. 25(8). 4232–4232. 9 indexed citations

Quagliariello, Vincenzo, Margherita Passariello, Andrea Paccone, et al.. (2024). Combinatorial immune checkpoint blockade increases myocardial expression of NLRP-3 and secretion of H-FABP, NT-Pro-BNP, interleukin-1β and interleukin-6: biochemical implications in cardio-immuno-oncology. Frontiers in Cardiovascular Medicine. 11. 1232269–1232269. 7 indexed citations

Inno, Alessandro, Giuseppe Bogina, Matteo Salgarello, et al.. (2023). First-line tepotinib for a very elderly patient with metastatic NSCLC harboring MET exon 14 skipping mutation and high PD-L1 expression. SHILAP Revista de lepidopterología. 17. 110–113. 3 indexed citations

Inno, Alessandro, et al.. (2023). Mucoepidermoid Carcinoma of the Lung Harboring MET Exon 14 Skipping Mutation Treated With Tepotinib: A Case Report. JCO Precision Oncology. 7(7). e2300136–e2300136.

10.

Incorvaia, Lorena, Lidia Rita Corsini, Chiara Brando, et al.. (2021). Challenges and advances for the treatment of renal cancer patients with brain metastases: From immunological background to upcoming clinical evidence on immune-checkpoint inhibitors. Critical Reviews in Oncology/Hematology. 163. 103390–103390. 5 indexed citations

11.

Inno, Alessandro, et al.. (2021). Current treatment options for HER2-positive breast cancer patients with brain metastases. Critical Reviews in Oncology/Hematology. 161. 103329–103329. 13 indexed citations

12.

Petrelli, Fausto, Alessandro Iaculli, Diego Signorelli, et al.. (2020). Survival of Patients Treated with Antibiotics and Immunotherapy for Cancer: A Systematic Review and Meta-Analysis. Preprints.org. 11 indexed citations

13.

Gori, Stefania, Monica Turazza, Alessandra Modena, et al.. (2018). When and how to treat women with HER2-positive, small (pT1a-b), node-negative breast cancer?. Critical Reviews in Oncology/Hematology. 128. 130–138. 7 indexed citations

14.

Inno, Alessandro, Sandro Barni, Antonio Ghidini, Alberto Zaniboni, & Fausto Petrelli. (2018). One year versus a shorter duration of adjuvant trastuzumab for HER2-positive early breast cancer: a systematic review and meta-analysis. Breast Cancer Research and Treatment. 173(2). 247–254. 24 indexed citations

15.

Tarantini, Luigi, Michele Massimo Gulizia, Andrea Di Lenarda, et al.. (2017). [ANMCO/AICO/AIOM Consensus document: Clinical and management pathways in cardio-oncology].. PubMed. 18(1). 14–66. 3 indexed citations

16.

Tarantini, Luigi, Michele Massimo Gulizia, Andrea Di Lenarda, et al.. (2017). Documento di consenso ANMCO/AICO/AIOM: Snodi clinico-gestionali in ambito cardioncologico. Giornale italiano di cardiologia. 18(1). 14–66. 2 indexed citations

17.

Tarantini, Luigi, Michele Massimo Gulizia, Andrea Di Lenarda, et al.. (2017). ANMCO/AIOM/AICO Consensus Document on clinical and management pathways of cardio-oncology: executive summary. European Heart Journal Supplements. 19(suppl_D). D370–D379. 24 indexed citations

18.

Salgarello, Matteo, et al.. (2016). 18F-NaF PET/CT Imaging of Brain Metastases. Clinical Nuclear Medicine. 41(7). 564–565. 15 indexed citations

19.

Pietrantonio, Filippo, Armando Orlandi, Alessandro Inno, et al.. (2015). Bevacizumab-based neoadjuvant chemotherapy for colorectal cancer liver metastases: Pitfalls and helpful tricks in a review for clinicians. Critical Reviews in Oncology/Hematology. 95(3). 272–281. 13 indexed citations

20.

Bogina, Giuseppe, Enrico Munari, Marcella Marconi, et al.. (2015). Neuroendocrine differentiation in breast carcinoma: clinicopathological features and outcome. Annals of Oncology. 26. vi137–vi137. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact